This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When atrialfibrillation (AF) begins, it can start with a single focus, degenerating to multiple wavelets, and it spreads throughout the entire surface area of both atria. A fibrillatory wave that occurs at a rate of more than 600 beats per minute can cause fatigue in the long run, leading to atrial dilation.
Specific cardiovascular diseases, such as acute myocardial infarction, arrhythmias, pulmonary hypertension and pericarditis, were also pointed. Elevated risk of arrhythmias, particularly atrialfibrillation, correlated with occupational silica exposure.
Common predictors include older age, prior hypertension, diabetes and atrialfibrillation. Heart failure (HF) is one of the significant complications in patients with myocardial infarction (MI), leading to increased risk for cardiovascular morbidity and mortality. HFrEF is more commonly.
Current guideline indications for intervention in asymptomatic patient are centred on left ventricular dimensions and ejection fraction and may include consideration in atrialfibrillation, pulmonary hypertension and those with left atrial dilatation.
male with pertinent past medical history including Atrialfibrillation, atrial flutter, cardiomyopathy, Pulmonary Embolism, and hypertension presented to the Emergency Department via ambulance for respiratory distress and tachycardia. Of course, this is NOT atrial fib, but rather PSVT, and so adenosine should work.
The term ‘epidemic’ is increasingly used to describe the rising global prevalence of atrialfibrillation (AF). The association between AF and various conditions—including hypertension, heart failure, sleep apnoea and chronic kidney disease—is well-described, highlighting that AF is often a multisystem disorder.
Background: Patients with atrialfibrillation (AF) and concomitant pulmonary hypertension (pHTN) have an increased risk of morbidity and mortality. However, the outcomes of catheter ablation in this cohort are unclear.
Objective This study explored factors that may influence blood pressure (BP) control in patients with atrialfibrillation (AF) with hypertension. BP control was assessed in patients with diagnosed AF and hypertension (controlled BP defined as <140/90 mm Hg). SD) years and 46.2% were female. had uncontrolled BP.
Atrialfibrillation (AF) is a prevalent arrhythmia in hypertensive patients and significantly increases mortality. Chronic inflammation plays a critical role in the pathophysiology of AF.
ABSTRACT There is a parallel epidemic of atrialfibrillation (AF) and hypertension (HTN) occurring globally. Both AF and HTN are no longer confined to the older population. The pathophysiology of AF related to HTN is complex with many inter-related factors.
A JACC study suggests that atrialfibrillation is far more prevalent than many previously thought, estimating that nearly one in 20 American adults have been diagnosed with the disease. That increase was greatest among younger patients, males, minorities, and patients with hypertension and diabetes. adult population.
Women who develop hypertensive disorders of pregnancy (HDOP) in their first delivery have a significantly increased cause-specific hazard ratio (csHR) of incident atrialfibrillation (AFib) compared with women who do not, according to a study published Feb.
Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for AtrialFibrillation Treatment 8. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) 10.
This article reviews the use of digital wearable technologies for monitoring of three common cardiovascular conditions: hypertension, heart failure, and atrialfibrillation.
A woman in her mid-60s with a history of paroxysmal atrialfibrillation and hypertension presents with 3 days of nausea, vomiting, and diarrhea. What would you do next?
Background Atrialfibrillation (AF), a common, frequently asymptomatic cardiac arrhythmia, is a major risk factor for stroke. 1720 (48%) were female, 1780 (50%) were hypertensive and 285 (8%) were current smokers. The Keele Decision Support tool was used to assess patients for oral anticoagulation (OAC).
BackgroundMultimorbidity is common among patients with atrialfibrillation (AF) and is associated with worse outcomes. Multimorbidity was defined as 2 comorbidities (heart failure, hypertension, diabetes, coronary heart disease, kidney dysfunction, moderate or severe mitral valve regurgitation, or obesity).
Objective Atrialfibrillation (AF) is a condition that occurs in the presence of comorbidities. years), obese and hypertensive cluster carrying an intermediate risk (5.9%) of incident AF. With the accumulation of comorbidities (multimorbidity), some combinations may more often occur together than others.
Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovascular disease (CVD), heart failure (HF), atrialfibrillation (AF), and multiple CVD risk factors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.
Objective Postoperative atrialfibrillation (POAF) is a common complication affecting approximately one-third of patients after cardiac surgery and valvular interventions. Two other associations provided highly suggestive evidence, including preoperative hypertension and neutrophil/lymphocyte ratio.
Here is the computer interpretation: ATRIALFIBRILLATION WITH RAPID VENTRICULAR RESPONSE WITH ABERRANT CONDUCTION OR VENTRICULAR PREMATURE COMPLEXES LEFT AXIS DEVIATION [QRS AXIS beyone -30] NONSPECIFIC ST and T-WAVE ABNORMALITY The over-reading physician confirmed this diagnosis, which is incorrect. It is not atrialfibrillation.
Background Atrialfibrillation (AF) following coronary artery bypass graft surgery (CABG) is common and results in significant increases in hospital stay and financial encumbrance. Objective Determine and use the predictors of postoperative AF (POAF) following CABG to develop a new predictive screening tool.
Heart failure with preserved ejection fraction (HFpEF) and atrialfibrillation (AF) are comorbid conditions that are increasingly prevalent and have a high socioeconomic burden. This article discusses their shared pathophysiology, focusing on the triad of hypertension, obesity, and aging.We
Hypertension is the single most important risk factor for development of atrialfibrillation (AF), which may be considered as a cardiac manifestation of hypertensive target organ damage. Furthermore, coexistence of hypertension and AF mutually amplifies the risk of complications, such as heart failure and stroke.
1 Atrialfibrillation (AF) is the most common cardiac arrhythmia, affecting more than 6 million individuals in the United States.2 2 As noted elsewhere,3 DM and AF affect a population that shares concomitant conditions such as obesity, hypertension and even heart failure (HF). of the population.1
BackgroundThe clinical utility of the polygenic risk score in predicting cardiovascular events in patients with atrialfibrillation (AF) has not yet been established. Journal of the American Heart Association, Ahead of Print.
We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% to 6.4%), atrialfibrillation (1.7% in 2020 to 61.0% Diabetes (16.3% to 26.8%) and obesity (43.1%
ABSTRACT Background Aging of the population has resulted in more patients living with atrialfibrillation (AF) and age-related macular degeneration (AMD). years, p <0.0001), and had higher rates of hypertension (50.0% AF is associated with macro- and micro-thromboembolism, microvascular dysfunction, and system inflammation.
(MedPage Today) -- LONDON -- A set of new European guidelines streamlined recommendations for atrialfibrillation (Afib), chronic coronary disease, peripheral artery disease (PAD) and aortic disease, and hypertension, with an emphasis on shared.
Back in the early 1990s, it was generally believed that the transition from paroxysmal to permanent AF was due to aging and/or the effect of an underlying cardiovascular disease such as hypertension, valvular defects, or heart failure.
Studies estimate that severe regurgitation occurs in up to 4% of individuals 75 and older and is often linked with conditions like heart failure, atrialfibrillation or pulmonary hypertension.
Introduction:Anticoagulation (AC) is the mainstay of thromboprophylaxis for stroke prevention in atrialfibrillation (AF) and is recommended. PSM components were age, gender, race, PPI use, anti-platelets, hypertension, coronary artery disease, heart failure, COPD, and CKD. We excluded patients with serum creatinine ≥ 1.5
Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrialfibrillation (AF) patients. Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH. Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025.
The human capital approach was used to estimate productivity losses from morbidity and premature mortality due to cardiovascular conditions.RESULTS:One in 3 US adults received care for a cardiovascular risk factor or condition in 2020.
BackgroundLeft heart disease is the most common cause of pulmonary hypertension (PH) and is frequently accompanied by increases in pulmonary vascular resistance. Accordingly, atrialfibrillation prevalence was significantly higher in CpcPH in a phenome‐wide analysis.
Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure. AF increases the risk of stroke, heart failure, dementia, and hospitalization.
Publication date: Available online 30 November 2023 Source: The American Journal of Cardiology Author(s): Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Javier Jimenez, Shebin George, Jiana Baker, Juan Ruiz, Sandra Chaparro
Background:Anticoagulation (AC) in patients with atrialfibrillation (AF) at high risk for stroke is strongly recommended in guidelines, but tracking the optimal use of AC at scale and across hospital systems is challenging due to the need to examine both thrombotic and bleeding risks that often factor in clinical decisions.
Background:Pulmonary hypertension (PH) and secondary right ventricle dysfunction is present in 20% of adults with coarctation of aorta (COA) based on echocardiographic studies. per 1 ml/mmHg), left atrial reservoir strain (adjusted OR 0.95, 95% CI 0921-0.98 per 1%), and atrialfibrillation (adjusted OR 2.18, 95% CI 1.20-13.5).
Multivariate linear regression analysis shows that the degree of anemia, atrialfibrillation, and TR were independently associated with the TAPSE/PASP ratio.ConclusionAnemia in HFpEF is associated with RV dysfunction, and this relationship is not affected by classical risk factors, such as smoking, hypertension, and diabetes.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding AtrialFibrillationAtrialFibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
AI-ECG prediction models developed at our institution can evaluate the probability of atrialfibrillation (AF) and estimate a patients age based on a normal sinus rhythm (NSR) ECG. Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content